Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Articles by Eurofins CDMO Alphora
Self Emulsifying Drug Delivery Systems (SEDDS): A Promising Approach To Improve Oral Bioavailability Of Poorly Soluble Compounds Original
By Hemang Joshi, Head of Formulation & Development, Drug Product Operations, Eurofins CDMO Alphora Poor water solubility is not a niche problem. It affects roughly 40% of new chemical entities and more than 90% of currently marketed drugs, making it one of the most persistent challenges in oral drug formulation.
Eurofins CDMO Alphora Expands Kilolab and High Potency Development and Manufacturing Capabilities
Indicators By: Eurofins CDMO Alphora via Business Wire August 13, 2026 at 10:00 AM EDT ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness. Eurofins CDMO Alphora has expanded its kilolab and high-potency active pharmaceutical ingredient (HPAPI) development and manufacturing capabilities in Mississauga.
Eurofins CDMO Alphora Expands Kilolab and High Potency Development and Manufacturing Capabilities
ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness. Eurofins CDMO Alphora has expanded its kilolab and high-potency active pharmaceutical ingredient (HPAPI) development and manufacturing capabilities in Mississauga.
Eurofins CDMO Alphora Joins International Consortium Project to Advance Next Generation ADC Expression Platform
Eurofins CDMO Alphora is pleased to announce that its Canadian-based division is receiving advisory services and funding from the National Research Council of Canada Industrial Research Assistance Program (NRC IRAP) to support a research and development collaboration project focused on advancing a transformative approach for next-generation ADC (antibody-drug conjugate) production to meet the growing demand for targeted therapeutics.
Eurofins CDMO Alphora Joins International Consortium Project to Advance Next Generation ADC Expression Platform
Eurofins CDMO Alphora is pleased to announce that its Canadian-based division is receiving advisory services and funding from the National Research Council of Canada Industrial Research Assistance Program (NRC IRAP) to support a research and development collaboration project focused on advancing a transformative approach for next-generation ADC (antibody-drug conjugate) production to meet the growing demand for targeted therapeutics.
Eurofins CDMO Alphora Announces Development & Implementation of AI-Powered Salt and Co-Crystal Screening Software
Eurofins CDMO Alphora is excited to announce the development and launch of a new AI-powered software for high throughput salt and co-crystal screening – now a core component of all solid-state screening programs. Developed by Eurofins CDMO Alphora, in collaboration with a local university, this cutting-edge machine learning platform provides highly accurate predictions of salt and co-crystal formation for APIs and intermediates.
Show More
loading
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with Eurofins CDMO
Contact Eurofins CDMO, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack